Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ: PHAT · Real-Time Price · USD
12.61
+0.45 (3.70%)
At close: Jul 10, 2026, 4:00 PM EDT
12.45
-0.16 (-1.26%)
After-hours: Jul 10, 2026, 7:55 PM EDT
Phathom Pharmaceuticals Market Cap
Phathom Pharmaceuticals has a market cap or net worth of $1 billion as of July 10, 2026. Its market cap has increased by 49.76% in one year.
Market Cap
1.00B
Enterprise Value
1.37B
1-Year Change
49.76%
Ranking
Category
Stock Price
$12.61
Market Cap Chart
Since October 25, 2019, Phathom Pharmaceuticals's market cap has increased from $527.13M to $1.00B, an increase of 90.01%. That is a compound annual growth rate of 10.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 1.00B | -15.13% |
| Dec 31, 2025 | 1.18B | 112.56% |
| Dec 31, 2024 | 555.22M | 6.22% |
| Dec 29, 2023 | 522.72M | 13.23% |
| Dec 30, 2022 | 461.63M | -22.48% |
| Dec 31, 2021 | 595.53M | -36.35% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 25, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Olema Pharmaceuticals | 1.04B |
| Vor Biopharma | 1.04B |
| Solid Biosciences | 1.03B |
| Kura Oncology | 1.02B |
| Avalo Therapeutics | 1.01B |
| Inventiva | 1.01B |
| Janux Therapeutics | 1.00B |
| Lexicon Pharmaceuticals | 986.12M |